This page is translated by Google and can contain errors. Go back to English.

News

Guide on non-conventional treatment options in breast cancer

ReDO: propranolol as an anti-cancer agent

Pantziarka, P., Bouche, G., Sukhatme, V., Meheus, L., Rooman, I., & Sukhatme, V. P. (2016). Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent. Ecancermedicalscience, 10, 680. doi:10.3332/ecancer.2016.680

ReDO: diclofenac as an anti-cancer agent

Pantziarka, P., Sukhatme, V., Bouche, G., Meheus, L., & Sukhatme, V. P. (2016). Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent. Ecancermedicalscience, 10, 610. doi:10.3332/ecancer.2016.610

ReDO: cimetidine as an anti-cancer agent

Pantziarka, P., Bouche, G., Meheus, L., Sukhatme, V., & Sukhatme, V. P. (2014). Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent. Ecancermedicalscience, 8, 485. doi:10.3332/ecancer.2014.485

Inconsistencies and questionable reliability of Yamamoto's publication on GcMAF

Ugarte, A., Bouche, G., & Meheus, L. (2014). Inconsistencies and questionable reliability of the publication "immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophages-activating, GcMAF" by Yamamoto et al. Cancer Immunology Immunotherapy, 63(12), 1347-8. doi: 10.1007/s00262-014-1587-y

Repurposing Drugs in Oncology (ReDO) Project

Pantziarka, P., Bouche, G., Meheus, L., Sukhatme, V., & Sukhatme, V. P. (2014). The Repurposing Drugs in Oncology (ReDO) Project. Ecancermedicalscience, 8, 442. doi:10.3332/ecancer.2014.442